Correlation Between Champions Oncology and Kymera Therapeutics
Can any of the company-specific risk be diversified away by investing in both Champions Oncology and Kymera Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Champions Oncology and Kymera Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Champions Oncology and Kymera Therapeutics, you can compare the effects of market volatilities on Champions Oncology and Kymera Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Champions Oncology with a short position of Kymera Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Champions Oncology and Kymera Therapeutics.
Diversification Opportunities for Champions Oncology and Kymera Therapeutics
0.03 | Correlation Coefficient |
Significant diversification
The 3 months correlation between Champions and Kymera is 0.03. Overlapping area represents the amount of risk that can be diversified away by holding Champions Oncology and Kymera Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Kymera Therapeutics and Champions Oncology is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Champions Oncology are associated (or correlated) with Kymera Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Kymera Therapeutics has no effect on the direction of Champions Oncology i.e., Champions Oncology and Kymera Therapeutics go up and down completely randomly.
Pair Corralation between Champions Oncology and Kymera Therapeutics
Given the investment horizon of 90 days Champions Oncology is expected to generate 1.14 times more return on investment than Kymera Therapeutics. However, Champions Oncology is 1.14 times more volatile than Kymera Therapeutics. It trades about 0.08 of its potential returns per unit of risk. Kymera Therapeutics is currently generating about -0.05 per unit of risk. If you would invest 398.00 in Champions Oncology on August 28, 2024 and sell it today you would earn a total of 20.00 from holding Champions Oncology or generate 5.03% return on investment over 90 days.
Time Period | 3 Months [change] |
Direction | Moves Together |
Strength | Insignificant |
Accuracy | 100.0% |
Values | Daily Returns |
Champions Oncology vs. Kymera Therapeutics
Performance |
Timeline |
Champions Oncology |
Kymera Therapeutics |
Champions Oncology and Kymera Therapeutics Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with Champions Oncology and Kymera Therapeutics
The main advantage of trading using opposite Champions Oncology and Kymera Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Champions Oncology position performs unexpectedly, Kymera Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Kymera Therapeutics will offset losses from the drop in Kymera Therapeutics' long position.Champions Oncology vs. Fonar | Champions Oncology vs. Burning Rock Biotech | Champions Oncology vs. Sera Prognostics | Champions Oncology vs. Exagen Inc |
Kymera Therapeutics vs. Foghorn Therapeutics | Kymera Therapeutics vs. Shattuck Labs | Kymera Therapeutics vs. Monte Rosa Therapeutics | Kymera Therapeutics vs. Nurix Therapeutics |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Funds Screener module to find actively-traded funds from around the world traded on over 30 global exchanges.
Other Complementary Tools
Portfolio Dashboard Portfolio dashboard that provides centralized access to all your investments | |
Portfolio Backtesting Avoid under-diversification and over-optimization by backtesting your portfolios | |
Bollinger Bands Use Bollinger Bands indicator to analyze target price for a given investing horizon | |
ETF Categories List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments | |
Sync Your Broker Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors. |